Teva Pharmaceuticals and IBM Partner to Develop Global Health Solutions

IBM has selected Israeli Teva Pharmaceutical Industries Ltd. as its first foundational life sciences partner for the Watson Health Cloud.

Financial terms of the partnership were not disclosed.

Earlier this year, IBM launched IBM Watson Health and the Watson Health Cloud platform.

Watson is an artificially intelligent computer system developed by IBM that is capable of answering questions posed in natural language. Watson is probably best known as the computer that took on, and defeated, past champions on the game show Jeopardy.

Teva has chosen the IBM Watson Health Cloud as a preferred global technology platform and aims to build solutions designed to help millions of individuals worldwide with complex and chronic conditions such as asthma, pain, migraine and neurodegenerative diseases. In addition, a joint Teva-IBM Research team will deploy Big Data and machine learning technology to create disease models and advanced therapeutic solutions.

Under the partnership  Teva becomes the first global pharmaceutical company to have access to the Watson Health Cloud.

Guy Hadari, Teva’s senior vice president and chief information officer, said the Watson Health Cloud provides a “strong foundation” for the company to fulfill the unmet and emerging patients’ needs through e-health.
Ambulance company owner charged; Fraud probe continues

“By building on the Watson Health Cloud, we believe Teva will be in a unique position to put the best information and insights in the hands of physicians, care teams and patients, to empower treatment optimization for individuals and populations across the spectrum of acute and chronic conditions, ” Hadari said in a statement.